The Screening Research of NF-κB Inhibitors from Moutan Cortex Based on Bioactivity-Integrated UPLC-QTOF-MS

المؤلفون المشاركون

Jiang, Min
Lu, Yujie
Liu, Wenjuan
Zhang, Man
Deng, Yanfang
Bai, Gang

المصدر

Evidence-Based Complementary and Alternative Medicine

العدد

المجلد 2019، العدد 2019 (31 ديسمبر/كانون الأول 2019)، ص ص. 1-7، 7ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2019-03-03

دولة النشر

مصر

عدد الصفحات

7

التخصصات الرئيسية

الطب البشري

الملخص EN

Inflammation is a common and important pathological process, and nuclear factor-κB (NF-κB) is a key mediator of it.

Moutan Cortex (MC), the dried root cortex of Paeonia suffruticosa Andr., is widely used as a remedy for the treatment of inflammatory diseases in Asian region.

However, there are few studies on the systematic identification of NF-κB inhibitors of MC.

In this study, the effect of inhibiting NF-κB activation of MC was assessed at the cellular level using a tumor necrosis factor-α (TNF-α) induced inflammatory model.

Subsequently, ultra-performance liquid chromatography-quadrupole/time of flight-mass spectrometry (UPLC-Q/TOF-MS) combined with biological activity assay was established to screen and identify potential anti-inflammatory ingredients in MC.

The results revealed that MC significantly inhibited the activation of NF-κB.

Seven potential NF-κB inhibitors were screened from MC, including oxypaeoniflorin, paeoniflorin, galloylpaeoniflorin, benzoyloxypaeoniflorin, mudanpioside C, gallic acid, and paeonol.

Among them, the NF-κB inhibitor activity of galloylpaeoniflorin, benzoyloxypaeoniflorin, and mudanpioside C is first reported here.

In conclusion, the anti-inflammatory activity of MC was associated with the seven components mentioned above.

And the bioactivity-integrated UPLC-Q/TOF which contains both chemical and bioactive details is suitable for screening active ingredients from natural medicines.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Lu, Yujie& Liu, Wenjuan& Zhang, Man& Deng, Yanfang& Jiang, Min& Bai, Gang. 2019. The Screening Research of NF-κB Inhibitors from Moutan Cortex Based on Bioactivity-Integrated UPLC-QTOF-MS. Evidence-Based Complementary and Alternative Medicine،Vol. 2019, no. 2019, pp.1-7.
https://search.emarefa.net/detail/BIM-1150377

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Lu, Yujie…[et al.]. The Screening Research of NF-κB Inhibitors from Moutan Cortex Based on Bioactivity-Integrated UPLC-QTOF-MS. Evidence-Based Complementary and Alternative Medicine No. 2019 (2019), pp.1-7.
https://search.emarefa.net/detail/BIM-1150377

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Lu, Yujie& Liu, Wenjuan& Zhang, Man& Deng, Yanfang& Jiang, Min& Bai, Gang. The Screening Research of NF-κB Inhibitors from Moutan Cortex Based on Bioactivity-Integrated UPLC-QTOF-MS. Evidence-Based Complementary and Alternative Medicine. 2019. Vol. 2019, no. 2019, pp.1-7.
https://search.emarefa.net/detail/BIM-1150377

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1150377